CELZ: Creative Medical Technology P/S Multiple

Creative Medical Technology (CELZ) management is facing a liquidity shortage due to clinical trial expenses. The historical P/S level visualizes the consequences of this pressure, where the 849.40 mark indicates the current state. Creative Medical Technology (CELZ) monetizes urology patents by creating unique AmnioStem cellular products to combat male infertility, allowing the company to occupy vacant niches in regenerative medicine.

CELZ - Creative Medical Technology Holdings Inc. P/S Multiple over the range 07/04/2022 - 05/09/2026

Analytical breakdowns for Creative Medical Technology (CELZ)

- current quotes and average value forecast:

Market Price creativemedicaltechnology.com|CELZ - Analyst Consensus Forecast

- market capitalization information:

Market Capitalization Creative Medical Technology Holdings Inc.|CELZ - Real Price to Acquire Entire Company

- balance sheet equity data:

Book Price of a Share Creative Medical Technology|CELZ - Book Capitalization|Market Capitalization to Book Value creativemedicaltechnology.com|CELZ - Cumulative Company Assets

- business debt structure and liquidity details:

Debt to Equity Creative Medical Technology|CELZ - Long-Term Debt to Capital|Current Liabilities to Capital creativemedicaltechnology.com|CELZ - Company Total Debt|Debt to Net Assets Ratio Creative Medical Technology Holdings Inc.|CELZ - Company Long-Term Debt|Company Current Liabilities Creative Medical Technology|Immediate Liquidity creativemedicaltechnology.com

- earnings and market ratios statistics:

CELZ - Net Profit|Net Profit Forecast Creative Medical Technology|CELZ - P/E Multiple|Market Cap to Projected Earnings creativemedicaltechnology.com|CELZ - PEG Multiple|Enterprise Value to EBITDA Ratio Creative Medical Technology Holdings Inc.|CELZ - Operating profit EBITDA|Net earnings per share (EPS TTM) Creative Medical Technology|CELZ - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months creativemedicaltechnology.com|CELZ - Net earnings per share growth this year|Expected earnings per share trend next year Creative Medical Technology

- issuer revenue and sales details:

CELZ - Company Sales|Company Projected Revenue Volume creativemedicaltechnology.com|CELZ - P/S Multiple|Market Cap to Future Revenue Ratio Creative Medical Technology Holdings Inc.

Summary company analytics:Creative Medical Technology Holdings, Inc., CELZ

Product sample of Creative Medical Technology Holdings Inc.

The P/S ratio is calculated as the ratio of market capitalization to total sales, measuring the value of one dollar of revenue in the eyes of investors. For Creative Medical Technology (CELZ), with its pristine image in the StemSpine and Stem cell therapy sectors, the median P/S serves as a filter for market noise, allowing for the determination of the fair value of assets relative to the business's actual earnings.

Competitors of Creative Medical Technology